Enveric BiosciencesSTU:SLZ0 30 Market Cap is €5.13 Mil as of Jul. 03, 2026. GuruFocus rates STU:SLZ0 with a GF Score™ of 30/100. The stock has 1 warning sign investors should review. Among 1,426 Biotechnology companies, Enveric Biosciences ranks worse than 89.83% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Enveric Biosciences's share price for the quarter that ended in Mar. 2026 was €55.89. Enveric Biosciences's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 1.89 Mil. Therefore, Enveric Biosciences's market cap for the quarter that ended in Mar. 2026 was €105.52 Mil.
Enveric Biosciences's quarterly market cap
increased
from Sep. 2025 (€28.95 Mil) to Dec. 2025 (€59.36 Mil) and
increased
from Dec. 2025 (€59.36 Mil) to Mar. 2026 (€105.52 Mil).
Enveric Biosciences's annual market cap
declined
from Dec. 2023 (€3.72 Mil) to Dec. 2024 (€3.32 Mil) but then
increased
from Dec. 2024 (€3.32 Mil) to Dec. 2025 (€59.36 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Enveric Biosciences's Enterprise Value for Today is €0.82 Mil.
Enveric Biosciences (STU:SLZ0) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Enveric Biosciences Market Cap Related Terms
Enveric Biosciences Market Cap Historical Data
* Premium members only.
The historical data trend for Enveric Biosciences's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:SLZ0 vs APVO, CNSP, ADIL: Market Cap Comparison
For the Biotechnology subindustry, Enveric Biosciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Enveric Biosciences Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Enveric Biosciences's Market Cap distribution charts can be found below:
* The bar in red indicates where Enveric Biosciences's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Enveric Biosciences's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enveric Biosciences (STU:SLZ0) has a Market Cap of €5.13 Mil as of Jul. 03, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Enveric Biosciences and its competitors. According to the industry distribution chart, Enveric Biosciences ranks #1281 out of 1426 companies in the Biotechnology industry, placing it in the top 89.8%.
Is Enveric Biosciences' Market Cap too high?
Enveric Biosciences' current Market Cap is €5.13 Mil. Based on the distribution chart, Enveric Biosciences ranks #1281 out of 1426 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Enveric Biosciences has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Enveric Biosciences' Market Cap compare to APVO and CNSP?
According to the Biotechnology industry distribution chart, Enveric Biosciences ranks #1281 out of 1426 companies for Market Cap. This places Enveric Biosciences in the lower half of its industry. The industry median Market Cap is 119.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 119.23, based on 1,426 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Enveric Biosciences and its competitors. For the Biotechnology industry, the median Market Cap is 119.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Enveric Biosciences's current Market Cap is €5.13 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enveric Biosciences stock overvalued right now?
Enveric Biosciences (STU:SLZ0) has a current Market Cap of €5.13 Mil. The current Market Cap is €5.13 Mil. Enveric Biosciences' overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Enveric Biosciences (STU:SLZ0), the current Market Cap is €5.13 Mil as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
30GF Score
Get the complete analysis for STU:SLZ0
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:SLZ0 has been successfully added to your 
